Target intelligence / Profile preview

PRAME family member 14 (PRAMEF14)

Target
PRAMEF14
Molecular classification
Other (PRAME family / Leucine-rich repeat-containing protein)
01

Overview

PRAME family member 14 (PRAMEF14) is a protein-coding gene located on chromosome 1 and part of the PRAME (Preferentially Expressed Antigen of Melanoma) gene family[2][6]. While PRAME itself is a well-studied cancer-testis antigen and a validated anti-cancer target in several malignancies, PRAMEF14 is a paralog whose function remains largely uncharacterized. It is predicted to be involved in biological processes such as the negative regulation of apoptotic process, but there is currently no specific published evidence indicating PRAMEF14 itself is a therapeutic target, disease driver, or biomarker in cancer or other pathologies[6]. Most available data concerns the broader PRAME family, and unlike PRAME, PRAMEF14 is not described as a bona fide cancer antigen or actionable therapeutic target[2][6]. No published evidence supports that PRAMEF14 itself is a validated receptor, enzyme, transporter, or therapeutic target[2][6]. Limited data exist on the biological or disease roles of PRAMEF14; information about the PRAME family does not directly equate to this specific family member. Aliases are accurate, but published literature and curated databases such as Ensembl and GDC list only gene/locus information for PRAMEF14, not functional data supporting targetability[2][6]. PRAME family member 14 (PRAMEF14) is a predicted member of the PRAME gene family but lacks adequate functional and clinical characterization to be considered a therapeutic target. Most published roles for PRAME pertain to the canonical PRAME protein, not PRAMEF14[2][6].

Other names
PRAME family member 14PRAMEF14OTTHUMG00000007916
02

Biological functions

Predicted negative regulation of apoptotic process
03

Disease associations

Other (no direct disease association or therapeutic relevance established for PRAMEF14; related PRAME family proteins implicated in cancer)

Beyond the preview

Go deeper on PRAME family member 14 (PRAMEF14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAME family member 14 (PRAMEF14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call